Bab's Hobbs Pharma Guide

Tag: biologics

Future Biosimilars: Upcoming Patent Expirations and Market Entry
Justine Traver

Future Biosimilars: Upcoming Patent Expirations and Market Entry

Biosimilars are set to transform healthcare as major biologics like Keytruda and Eylea lose patent protection between 2025 and 2030. With savings up to 35%, these drugs offer the same effectiveness at a fraction of the cost - changing how patients, providers, and payers access life-saving treatments.

18 Jan 2026

Browse by category

  • Health & Wellness (231)

Latest news

  • Can Sertraline Prevent Migraines? Benefits, Risks & Evidence
  • Understanding Controlled Substance Labels and Schedule Codes
  • How to Buy Generic Seroquel (Quetiapine) Online Safely and Cheaply in 2026
  • How to Create a Family Overdose Emergency Plan for Medications
  • Why Generic Drugs Look Different: Trademark Laws and Safety

Posts Tags

  • drug interactions
  • online pharmacy
  • side effects
  • bioequivalence
  • medication safety
  • online pharmacy safety
  • medication reconciliation
  • generic drugs
  • patient safety
  • medication side effects
  • Hatch-Waxman Act
  • medication errors
  • generic medications
  • expired medications
  • medication adherence
  • generic medication
  • patent expiration
  • authorized generics
  • narrow therapeutic index
  • generic drug safety
Bab's Hobbs Pharma Guide
Menu
  • About
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact

© 2026. All rights reserved.